The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Extraintestinal manifestations in inflammatory bowel disease
Open accessAbstract
Inflammatory bowel diseases (IBD) can be really considered to be systemic diseases since they are often associated with extraintestinal manifestations, complications, and other autoimmune disorders. Indeed, physicians who care for patients with ulcerative colitis and Crohn's disease, the two major forms of IBD, face a new clinical challenge every day, worsened by the very frequent rate of extraintestinal complications. The goal of this review is to provide an overview and an update on the extraintestinal complications occurring in IBD. Indeed, this paper highlights how virtually almost every organ system can be involved, principally eyes, skin, joints, kidneys, liver and biliary tracts, and vasculature (or vascular system) are the most common sites of systemic IBD and their involvement is dependent on different mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Dougados, M., Linden, S. V. D., Juhlin, R., Huitfeldt, B., Amor, B., Calin, A., Cats, A., Dijkmans, B., Olivieri, I., Pasero, G., et al. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341003 · Cited by 2,299
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., Balish, E., & Hammer, R. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2359 · Cited by 1,156
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
Schwartz, D. A., Loftus, E. V., Tremaine, W. J., Panaccione, R., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32362 · Cited by 1,144
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
Wiesner, R. H., Grambsch, P. M., Dickson, R. E., Ludwig, J., Maccarty, R. L., Hunter, E. B., Fleming, T. R., Fisher, L. D., Beaver, S. J., & Larusso, N. F. (1989) · Hepatology · doi:10.1002/hep.1840100406 · Cited by 643
Vascular Complications of Inflammatory Bowel Disease
TALBOT, R. W., HEPPELL, J., DOZOIS, R. R., & BEART, R. W. (1986) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65200-8 · Cited by 630
Orchard, T. R., Wordsworth, B. P., & Jewell, D. P. (1998) · Gut · doi:10.1136/gut.42.3.387 · Cited by 549
Effect of inflammatory cytokines on hypoxia-induced erythropoietin production
Faquin, W., Schneider, T., & Goldberg, M. (1992) · Blood · doi:10.1182/blood.v79.8.1987.1987 · Cited by 532
Iron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
Miehsler, W., Reinisch, W., Valic, E., Osterode, W., Tillinger, W., Feichtenschlager, T., Grisar, J., Machold, K., Scholz, S., Vogelsang, H., et al. (2004) · Gut · doi:10.1136/gut.2003.025411 · Cited by 479
Bernstein, C. N., Blanchard, J. F., Leslie, W., Wajda, A., & Yu, B. N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-10-200011210-00012 · Cited by 474
Veloso, F. T., Carvalho, J., & Magro, F. (1996) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199607000-00009 · Cited by 373
Eksteen, B., Grant, A. J., Miles, A., Curbishley, S. M., Lalor, P. F., Hübscher, S. G., Briskin, M., Salmon, M., & Adams, D. H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041035 · Cited by 360
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
Mitchell, S. A., Bansi, D. S., Hunt, N., Bergmann, K. V., Fleming, K. A., & Chapman, R. W. (2001) · Gastroenterology · doi:10.1053/gast.2001.27965 · Cited by 351
Venous Thromboembolism in Inflammatory Bowel Disease
Solem, C. A., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04026.x · Cited by 317
Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation
Boberg, K. M., Bergquist, A., Mitchell, S., Pares, A., Rosina, F., Broomé, U., Chapman, R., Fausa, O., Egeland, T., Rocca, G., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202760373434 · Cited by 311
Viereck, V., Emons, G., Lauck, V., Frosch, K.-H., Blaschke, S., Gründker, C., & Hofbauer, L. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6510 · Cited by 310
Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study
Felder, J. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01054-6 · Cited by 290
Regueiro, M., & Mardini, H. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200303000-00003 · Cited by 288
Redlich, K., Hayer, S., Maier, A., Dunstan, C. R., Tohidast‐Akrad, M., Lang, S., Türk, B., Pietschmann, P., Woloszczuk, W., Haralambous, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10097 · Cited by 285
Genetic markers may predict disease behavior in patients with ulcerative colitis
Roussomoustakaki, M., Satsangi, J., Welsh, K., Louis, E., Fanning, G., Targan, S., Landers, C., & Jewell, D. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178675 · Cited by 275
Papadaki, H. A., Kritikos, H. D., Valatas, V., Boumpas, D. T., & Eliopoulos, G. D. (2002) · Blood · doi:10.1182/blood-2002-01-0136 · Cited by 262
Association of primary sclerosing cholangitis with HLA-B8.
Chapman, R. W., Varghese, Z., Gaul, R., Patel, G., Kokinon, N., & Sherlock, S. (1983) · Gut · doi:10.1136/gut.24.1.38 · Cited by 260
Inflammatory bowel disease and the risk of fracture
Van staa, T.-P., Cooper, C., Samuels Brusse, L., Leufkens, H., Javaid, M. K., & Arden, N. K. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.027 · Cited by 245
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis
Harnois, D. M., Angulo, P., Jorgensen, R. A., LaRusso, N. F., & Lindor, K. D. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03777.x · Cited by 242
Clinical patterns of familial inflammatory bowel disease.
Satsangi, J., Grootscholten, C., Holt, H., & Jewell, D. P. (1996) · Gut · doi:10.1136/gut.38.5.738 · Cited by 238
Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease
Regueiro, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00430-1 · Cited by 221
Van den Bosch, F., Kruithof, E., Vos, M. D., Keyser, F. D., & Mielants, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03239-6 · Cited by 220
Ocular Manifestations of Inflammatory Bowel Disease
Mintz, R., Feller, E. R., Bahr, R. L., & Shah, S. A. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200403000-00012 · Cited by 211
Infliximab in the treatment of Crohn's disease: a user's guide for clinicians
Sandborn, W. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05510-7 · Cited by 203
Das, K. M. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026629528233 · Cited by 190
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
Vestergaard, P., Krogh, K., Rejnmark, L., Laurberg, S., & Mosekilde, L. (2000) · Gut · doi:10.1136/gut.46.2.176 · Cited by 186
Vidal, N., Brandstrom, H., Jonsson, K., & Ohlsson, C. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590191 · Cited by 185
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
Stein, R. B., & Hanauer, S. B. (2000) · Drug Safety · doi:10.2165/00002018-200023050-00006 · Cited by 167
Hepatobiliary Dysfunction and Primary Sclerosing Cholangitis in Patients with Crohn's Disease
Rasmussen, H. H., Fallingborg, J. F., Mortensen, P. B., Vyberg, M., Tage-Jensen, U., & Rasmussen, S. N. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709025107 · Cited by 166
Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease
Mahadevan, U., Loftus, E. V., Tremaine, W. J., & Sandborn, W. J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05608.x · Cited by 155
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
Haderslev, K. V., Tjellesen, L., Sørensen, H. A., & Staun, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.16518 · Cited by 155
Methotrexate in Crohn's Disease: Long-Term Efficacy and Toxicity
Lémann, M., Zenjari, T., Bouhnik, Y., et al. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02190.x · Cited by 147
Generini, S., Giacomelli, R., Fedi, R., Fulminis, A., Pignone, A. M., Frieri, G., Rosso, A. D., Viscido, A., Galletti, B., Fazzi, M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012450 · Cited by 142
Primary Sclerosing Cholangitis
Talwalkar, J. A., & Lindor, K. D. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00009 · Cited by 137
Risk of colorectal neoplasia in patients with primary sclerosing cholangitis
Loftus, E. V., Sandborn, W., Tremaine, W., Mahoney, D., Zinsmeister, A., Offord, K., & Melton, L. J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8566590 · Cited by 136
Geng, X., Biancone, L., Dai, H. H., Lin, J. J.-C., Yoshizaki, N., Dasgupta, A., Pallone, F., & Das, K. M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70310-5 · Cited by 135
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
Chapman, R. W., Cottone, M., Selby, W. S., Shepherd, H. A., Sherlock, S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.1.86 · Cited by 135
The osteoporosis care gap in Canada
Παπαϊωάννου, Α., Giangregorio, L., Kvern, B. L., Boulos, P., Ioannidis, G., & Adachi, J. (2004) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-5-11 · Cited by 132
Angulo, P., Therneau, T. M., Jorgensen, R. A., DeSotel, C. K., Egan, K. S., Dickson, E. R., Hay, J. E., & Lindor, K. D. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80253-5 · Cited by 126
Inflammatory Bowel Disease Promotes Venous Thrombosis Earlier in Life
Grip, O., Svensson, P. J., & Lindgren, S. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023589 · Cited by 122
Iron and inflammatory bowel disease
Oldenburg, B., Koningsberger, J. C., Henegouwen, G. P. V. B., van Asbeck, B. S., & Marx, J. J. M. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00930.x · Cited by 122
Okolicsànyi, L., Fabris, L., Viaggi, S., Carulli, N., Podda, M., & Ricci, G. (1996) · PubMed · Cited by 120
Genetic factors determine extent of bone loss in inflammatory bowel disease
Schulte, C. M. S., Dignass, A. U., Goebell, H., Röher, H.-D., & Schulte, K. (2000) · Gastroenterology · doi:10.1053/gast.2000.18158 · Cited by 114
The effect of infliximab on extraintestinal manifestations of Crohn’s disease
Kaufman, I., Caspi, D., Yeshurun, D., Dotan, I., Yaron, M., & Elkayam, O. (2004) · Rheumatology International · doi:10.1007/s00296-004-0467-8 · Cited by 113
Review Article: Inherited Thrombophilia in Inflammatory Bowel Disease
Papa, A., Danese, S., Grillo, A., Gasbarrini, A., & Gasbarrini, A. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07491.x · Cited by 112
Self-citation(2003) · Gastroenterology · doi:10.1053/gast.2003.50107 · Cited by 111
Homocysteine in Inflammatory Bowel Disease: A Risk Factor for Thromboembolic Complications?
Oldenburg, B., Fijnheer, R., van der Griend, R., et al. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03193.x · Cited by 110
Herfarth, H. H., Obermeier, F., Andus, T., Rogler, G., Nikolaus, S., Kuehbacher, T., & Schreiber, S. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06064.x · Cited by 110
Wang, C. Q., Udupa, K. B., & Lipschitz, D. A. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620116 · Cited by 107
van Hoogstraten, H. J. F. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01059-5 · Cited by 107
Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia
Gasché, C., Waldhoer, T., Feichtenschlager, T., Male, C., Mayer, A., Mittermaier, C., & Petritsch, W. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04094.x · Cited by 101
Stockbrügger, R. W., Schoon, E. J., Bollani, S., Mills, P. R., Israeli, E., Landgraf, L., Felsenberg, D., Ljunghall, S., Nygård, G., Persson, T., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01317.x · Cited by 99
Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients
Boberg, K. M., Egeland, T., & Schrumpf, E. (2003) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310005172 · Cited by 93
Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis
Rost, D., Rudolph, G., Kloeters-Plachky, P., & Stiehl, A. (2004) · Hepatology · doi:10.1002/hep.20370 · Cited by 90
Clinical investigation of methotrexate in the treatment of ankylosing spondylitis
Altan, Ü. B. L., Bingöl, Ü., & Karakoç, Y. (2001) · Scandinavian Journal of Rheumatology · doi:10.1080/030097401753180318 · Cited by 90
Dermatologic Manifestations of Crohn Disease in Children: Response to Infliximab
Kugathasan, S., Miranda, A., Nocton, J. J., Drolet, B. A., Raasch, C., & Binion, D. G. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200308000-00013 · Cited by 89
Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab
Fries, W., Giofré, M. R., Catanoso, M., & Gullo, R. L. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05514.x · Cited by 85
Peeters, H., Cruyssen, B. V., Laukens, D., Coucke, P. J., Marichal, D., Berghe, M. V. D., Cuvelier, C. A., Remaut, E., Mielants, H., Keyser, F. D., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.021774 · Cited by 83
van Hoogstraten, H. J. F., Vleggaar, F. P., Boland, G. J., Steenbergen, W. V., Griffioen, P. H., Hop, W. C. J., van Hattum, J., Henegouwen, G. P. V. B., Schalm, S. W., van Buuren, H. R., et al. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02267.x · Cited by 83
Buxton, E. C., Yao, W., & Lane, N. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032066 · Cited by 79
Rare Extraintestinal Manifestations of Inflammatory Bowel Disease
Hoffmann, R. M., & Kruis, W. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200403000-00013 · Cited by 74
Oldenburg, B., van Tuyl, B. A. C., van der Griend, R., et al. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1588-y · Cited by 69
Bone density improves with disease remission in patients with inflammatory bowel disease
Reffitt, D. M., Meenan, J. K., Sanderson, J. D., Jugdaohsingh, R., Powell, J. J., & Thompson, R. P. H. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200312000-00003 · Cited by 69
Bernstein, C. N., Blanchard, J., Metge, C. J., & Yogendran, M. S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07590.x · Cited by 62
Salmi, M., Alanen, K. A., Grénman, S., Briskin, M., Butcher, E. C., & Jalkanen, S. (2001) · Gastroenterology · doi:10.1053/gast.2001.27968 · Cited by 59
Bone disease in inflammatory bowel disease
Schulte, C. M. S. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02057.x · Cited by 45
Complications of inflammatory bowel disease.
Gasché, C. (2000) · PubMed · Cited by 43
Nash, C., Panaccione, R., Sutherland, L. R., & Meddings, J. B. (2001) · Canadian Journal of Gastroenterology · doi:10.1155/2001/954340 · Cited by 33
Baker, D. E., & Kane, S. V. (2004) · PubMed · Cited by 28
Evidence-based treatment algorithm for mild to moderate Crohn's disease
Sandborn, W. J. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.10.007 · Cited by 22
Cited by
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Extraintestinal Manifestations of Inflammatory Bowel Disease
Vavricka, S. R., Schoepfer, A., Scharl, M., Lakatos, P. L., Navarini, A., & Rogler, G. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000392 · Cited by 909
Dignass, A., Eliakim, R., Magro, F., Maaser, C., Chowers, Y., Geboes, K., Mantzaris, G., Reinisch, W., Colombel, J.-F., Vermeire, S., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.003 · Cited by 888
Henke, M. T., Kenny, D. J., Cassilly, C. D., Vlamakis, H., Xavier, R. J., & Clardy, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904099116 · Cited by 812
Metadata
- Authors
- Danese, S.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2005
- Volume
- 11
- Issue
- 46
- Pages
- 7227
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2165864117
- Cited by
- 373
- References
- 80
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.